\n\t\t\t\t\t\t\t\t\tTirzepatide is a synthetic peptide designed to activate two hormone receptors: GIP<\/strong> and GLP-1<\/strong>. These receptors are part of the body\u2019s normal incretin system, which helps regulate insulin release, blood sugar, appetite, and energy balance.\n\nTirzepatide has been extensively studied in clinical trials as an authorized medicine in certain finished drug products.\n

\nResearch Areas<\/strong>\n

\n \t
• GIP receptor signalling<\/li>\n \t
• GLP-1 receptor signalling<\/li>\n \t
• Incretin biology<\/li>\n \t
• Blood-sugar regulation research<\/li>\n \t
• Appetite-regulation pathways<\/li>\n \t
• Metabolic signalling<\/li>\n<\/ul>\nProduct Highlights<\/strong>\n
  \n \t
  • Dual GIP \/ GLP-1 research peptide<\/li>\n \t
  • Lot-specific supplier COA available<\/li>\n \t
  • Batch documentation available<\/li>\n \t
  • Lyophilized research material<\/li>\n<\/ul>\nResearch Use Notice<\/strong>\n\nFor laboratory research only. Not for human or veterinary use. This product is not Mounjaro\u00ae, Zepbound\u00ae, or another authorized finished prescription drug.\n\n
    \n\n